Evidence map›Paper›PMID 42348514›Full record

ArticlePloS one2026

Enhanced IGFL1 translation in response to IL-1β is controlled by distinct 3'UTR elements.

Giulia Cardamone, Melanie Flohr, Rebecca Raue, Irina Bode, Sofie P Meyer, Sven Hauns, Rolf Backofen, Tobias Schmid

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Giulia CardamoneInstitute of Biochemistry I, Faculty of Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0002-4176-6710
Melanie FlohrInstitute of Biochemistry I, Faculty of Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany.
Rebecca RaueInstitute of Biochemistry I, Faculty of Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany.
Irina BodeInstitute of Biochemistry I, Faculty of Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0002-4893-852X
Sofie P MeyerInstitute of Biochemistry I, Faculty of Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany.
Sven HaunsChair of Bioinformatics, University of Freiburg, Freiburg, Germany.ORCID https://orcid.org/0000-0002-5492-1871
Rolf BackofenChair of Bioinformatics, University of Freiburg, Freiburg, Germany.
Tobias SchmidInstitute of Biochemistry I, Faculty of Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0002-1952-5259

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Translation is a crucial regulatory mechanism involved in several diseases, including cancer, where pro-inflammatory conditions within the microenvironment have been shown to modulate the translation of specific mRNAs. In the present study, we focused on the regulation of insulin growth factor-like family member 1 (IGFL1) in MCF7 breast cancer cells in response to pro-inflammatory IL-1β and observed an induction of both transcription and translation. We characterized the 3' untranslated region as regulatory hub for the post-transcriptional regulation and identified a distinct G-rich region to confer the IL-1β-dependent translational increase. Our study therefore provides new insights into the translation regulation of IGFL1 in the context of an inflammatory tumor microenvironment.

Indexed as

3' Untranslated RegionsInsulin-Like PeptidesInterleukin-1betaProtein BiosynthesisGene Expression Regulation, NeoplasticHumansMCF-7 CellsRNA, Messenger3' Untranslated RegionsInsulin-Like PeptidesInterleukin-1betaRNA, Messenger

Identifiers

PMID42348514
PMCPMC13298950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.